NCT00709423View on ClinicalTrials.gov

Effects of Moxaverine and Placebo on Ocular Blood Flow

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Regional Blood FlowOcular PhysiologyRetina
Interventions
DRUG

Moxaverine

DRUG

Moxaverin 150mg

intravenous administration

DRUG

NaCl

intravenous administration

Trial Locations (1)

1090

Department of Clincal Pharmacology, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00709423 - Effects of Moxaverine and Placebo on Ocular Blood Flow | Biotech Hunter | Biotech Hunter